Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

Diabetes is too serious to be left solely to the medical professionals, Jitendra Singh, Union minister for earth sciences and science and technology, said as he advocated for increasing public-private ...

Signs of type 2 diabetes typically manifest as fatigue, increased thirst and blurry vision. But how can you tell if you're ...

Trends in child health are in fact worrisome, and scientists welcome a renewed focus on foods and environmental toxins. But ...

Ashley Bertino sat in a courtroom as witnesses testified about the medical neglect that allegedly led to her daughter's death ...

Think of the way bad health concerns are a part of your family history as your health legacy. Fortunately, you can reduce the ...

A delay in the FDA decision for NT-501 could leave those with macular telangiectasia (MacTel) without any form of treatment ...

Timely care and support help HIV patients reach a zero-transmission goal. Harris Health's READI program shows how to manage ...

A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...

For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

Pancreatic cancer develops quietly, with symptoms that may seem insignificant at first glance. This cancer affects the ...

Prediabetes is almost always a precursor to type 2 diabetes — but it doesn’t have to lead to that outcome. Experts share ...